Health
Three lessons from Covid-19 on accelerating biopharma innovation – STAT
Innovation in biopharma research and development being wrought by Covid-19 will improve R&D in cancer and other fields.
The health care research ecosystem has shifted into overdrive in response to Covid-19, sparking unprecedented speed and agility. The economic and public health burdens it has generated demand that we rethink our approach to developing new vaccines and therapies. Researchers are now examining what we can learn from these experiences and more broadly apply this innovation to research and development in the future.
As we look back at the past few months, I see three lessons that health care resear…
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Business10 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News21 hours agoBrisbane’s covert cameras catching more than just litterbugs